Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3278598578;98579;98580 chr2:178539712;178539711;178539710chr2:179404439;179404438;179404437
N2AB3114493655;93656;93657 chr2:178539712;178539711;178539710chr2:179404439;179404438;179404437
N2A3021790874;90875;90876 chr2:178539712;178539711;178539710chr2:179404439;179404438;179404437
N2B2372071383;71384;71385 chr2:178539712;178539711;178539710chr2:179404439;179404438;179404437
Novex-12384571758;71759;71760 chr2:178539712;178539711;178539710chr2:179404439;179404438;179404437
Novex-22391271959;71960;71961 chr2:178539712;178539711;178539710chr2:179404439;179404438;179404437
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCT
  • RefSeq wild type template codon: CGA
  • Domain: Ig-155
  • Domain position: 78
  • Structural Position: 168
  • Q(SASA): 0.3711
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/G None None 0.22 N 0.377 0.192 0.395441342475 gnomAD-4.0.0 1.36844E-06 None None None None N None 0 0 None 0 0 None 0 0 1.7989E-06 0 0
A/V rs2154140130 None None N 0.164 0.143 0.363158594168 gnomAD-4.0.0 2.05266E-06 None None None None N None 0 0 None 0 0 None 0 0 8.99452E-07 2.31863E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.568 likely_pathogenic 0.6156 pathogenic -0.569 Destabilizing 0.909 D 0.407 neutral None None None None N
A/D 0.4652 ambiguous 0.6128 pathogenic -0.867 Destabilizing 0.497 N 0.479 neutral N 0.436858362 None None N
A/E 0.3761 ambiguous 0.5052 ambiguous -0.883 Destabilizing 0.272 N 0.407 neutral None None None None N
A/F 0.4718 ambiguous 0.5852 pathogenic -0.671 Destabilizing 0.567 D 0.547 neutral None None None None N
A/G 0.2276 likely_benign 0.268 benign -0.789 Destabilizing 0.22 N 0.377 neutral N 0.517916733 None None N
A/H 0.5963 likely_pathogenic 0.6931 pathogenic -0.848 Destabilizing 0.968 D 0.551 neutral None None None None N
A/I 0.3102 likely_benign 0.4102 ambiguous -0.096 Destabilizing 0.157 N 0.417 neutral None None None None N
A/K 0.5631 ambiguous 0.7009 pathogenic -0.943 Destabilizing 0.567 D 0.411 neutral None None None None N
A/L 0.2567 likely_benign 0.3347 benign -0.096 Destabilizing 0.072 N 0.428 neutral None None None None N
A/M 0.2326 likely_benign 0.2943 benign -0.238 Destabilizing 0.726 D 0.465 neutral None None None None N
A/N 0.3122 likely_benign 0.4145 ambiguous -0.71 Destabilizing 0.567 D 0.523 neutral None None None None N
A/P 0.5637 ambiguous 0.6929 pathogenic -0.212 Destabilizing 0.667 D 0.433 neutral N 0.469874857 None None N
A/Q 0.4334 ambiguous 0.5188 ambiguous -0.824 Destabilizing 0.726 D 0.457 neutral None None None None N
A/R 0.5155 ambiguous 0.6417 pathogenic -0.618 Destabilizing 0.567 D 0.442 neutral None None None None N
A/S 0.1191 likely_benign 0.1392 benign -0.99 Destabilizing 0.124 N 0.436 neutral N 0.379367496 None None N
A/T 0.1052 likely_benign 0.1428 benign -0.912 Destabilizing None N 0.163 neutral N 0.38507996 None None N
A/V 0.1585 likely_benign 0.2034 benign -0.212 Destabilizing None N 0.164 neutral N 0.434684848 None None N
A/W 0.8286 likely_pathogenic 0.8845 pathogenic -1.036 Destabilizing 0.968 D 0.685 prob.neutral None None None None N
A/Y 0.5931 likely_pathogenic 0.6853 pathogenic -0.598 Destabilizing 0.726 D 0.555 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.